Basma Adeem Medical Co. 9626
TADAWUL · Saudi Arabia · Health Services
SAR 6.100.00 (0.00%)
Market closed· · SAR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SAR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
These ratios divide the lines in the statements below by the current price; both inputs of every value are visible on this page. The P/E on the overview comes from the same calculation. P/E and P/S are left blank for loss-making companies or where revenue is not reported. Not investment advice.
| FY2025 | FY2024 | |
|---|---|---|
| Revenue | SAR 45.46M | SAR 33.92M |
| Revenue growth (YoY) | +34.0% | — |
| Cost of Revenue | MakklerPRO | MakklerPRO |
| Gross Profit | MakklerPRO | MakklerPRO |
| Gross margin | MakklerPRO | MakklerPRO |
| Operating expenses | MakklerPRO | MakklerPRO |
| Operating Income | MakklerPRO | MakklerPRO |
| Operating margin | MakklerPRO | MakklerPRO |
| EBITDA | MakklerPRO | MakklerPRO |
| Pre-tax income | MakklerPRO | MakklerPRO |
| Income tax | MakklerPRO | MakklerPRO |
| Net Income | SAR 7.30M | SAR 6.30M |
| Net margin | MakklerPRO | MakklerPRO |
| Diluted EPS | MakklerPRO | MakklerPRO |
| Diluted shares | MakklerPRO | MakklerPRO |
| FY2025 | FY2024 | |
|---|---|---|
| Cash & equivalents | MakklerPRO | MakklerPRO |
| Total Current Assets | MakklerPRO | MakklerPRO |
| Total Assets | SAR 66.23M | SAR 37.89M |
| Total Current Liabilities | MakklerPRO | MakklerPRO |
| Total Liabilities | MakklerPRO | MakklerPRO |
| Total debt | MakklerPRO | MakklerPRO |
| Total Equity | MakklerPRO | MakklerPRO |
| FY2025 | FY2024 | |
|---|---|---|
| Cash from Operations | SAR 11.37M | SAR 7.98M |
| Free cash flow | MakklerPRO | MakklerPRO |
| Cash from Investing | MakklerPRO | MakklerPRO |
| Cash from Financing | MakklerPRO | MakklerPRO |
Standardised statements compiled from the company's annual and interim reports. The "LTM" column covers the last four reported quarters; balance-sheet lines in it are from the latest quarter. Lines the company does not report are left blank rather than approximated. Not investment advice.